The BP reading that matters most happens at 2am

ACC/AHA guidelines have called for 24-hour Ambulatory Blood Pressure monitoring. Biobeat makes it frictionless - for you and for your patient.

Fewer than 0.5% of insured hypertension patients have ever had an ABPM claim on file. Up to 35% are misclassified, because office readings can’t capture a full 24 hours – day and night data.
Biobeat’s FDA-cleared cuffless Ambulatory Blood Pressure monitor closes that gap:

No cuff inflation, no sleep disruption, no device to return
24-hour monitoring via a disposable chest patch
Auto-generated report sent to you the moment the test ends: BP trends, nighttime averages, dipping patterns, morning surge, cardiac output, and patient diary overlay
Accurate across sex, BMI and all Fitzpatrick skin tones
Integrates with EPIC

Validated against invasive arterial line monitoring across ~80,000 paired measurements (r = 0.96-0.97, Journal of Human Hypertension) and against gold-standard cuff ABPM (American Journal of Hypertension).

Billing uses the same CPT codes as standard ABPM.
The physician kit includes our clinical validation white paper, workflow overview, and product specs.

What physicians say after going cuffless

"This enables me to tailor treatment plans more effectively, resulting in better patient outcomes."

"This has been invaluable in diagnosing and managing hypertension."

Request your clinical evidence knowledge kit

Trends in ambulatory blood pressure monitoring used for confirmation or monitoring of hypertension and resistant hypertension among the commercially insured in the U.S., 2008-2017

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000596

https://pubmed.ncbi.nlm.nih.gov/17620947/

Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients, , Lancet 2023; 401: 2041–50